Study title: A Single-Blind, Comparative Study of Ivermectin (MK-933) and Placebo on the Effect and Intake and Development of Onchocerca Volvulus Microfilariae in Simulium Sirbanum Fed on Patients with Onchocerciasis.
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Parasitic Diseases | |||||
Brands: Please see report, Please see report, Please see report | |||||
MAH holders: Please see report, Please see report, Please see report | |||||
Assessment: | |||||
Active substance: IVERMECTIN | |||||
ATC code: P02CF01 | |||||
Document link: Stromectol_Ivermectin_517_Synopsis.pdf | |||||
Document date: 2011-10-17 | |||||
Study number: Protocol J-22/ 517 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |